Yes, not much selling but not much buying either. Very low

New Post Public Reply Private Reply Replies (0) Message Board
EliteYoda The Illest #8970

Yes, not much selling but not much buying either. Very low volume with only about 1% of the float trading hands (allegedly), yet the PPS fluctuating wildly and the market cap taken down 12% to just a few ticks over par value for the stock and right about at the average cost basis for Ironridge as far as we can tell. About 43% short volume versus total volume today, business as usual. RFMK has to be the most massively shorted PK stock I have ever witnessed. The massive short selling continues and there seemingly is no end in sight. Every single day this stock is getting shorted to a gigantic degree for as many months as I cared to look. There was recently a very brief period of time wherein the daily short transaction volume fell down to about 10% but it only lasted a day or two and then went right back up to 35% to 45% shorting. For many months CBIS had very little short sale volume, stable at about 10% but just recently it too has risen up to about the same as RFMK today, near 43%, as volume has fallen in both stocks. Same story for HEMP.

I am not really sure what these market participants are thinking taking on so much risk down here a few ticks away from par value and triple zero ranges, all in a low volume environment. A 100% rise in the stock would see the stock back at the 200 day moving average. The stock is extremely thin and volatile so focusing on percentage price changes is meaningless, IMO. Seeing that a double in the stock from current levels puts it back at the 200 day moving average somewhat shows how ridiculous the notion is that skillful PK traders do well to only take their 30% or 40% gains or whatever the statements are, and no more, because a trader pressing for larger gains is just gambling. Well, actually, first of all it would not take much actual money trading hands to see this stock up 100%, and secondly, what is gambling is throwing a traders full powder into a trade at a few very close price levels and just playing the random PK fluctuations for a day or two and attempting to capture a 30%+ move. It can easily go the other way and then what? Just a few days like today of 12%+ losses and the trader is to cut and run? Is that the strategy? I assure all the quick draw traders out there, it does not take much common sense to realize that such a flipping strategy in such a thin volatile stock is extremely risky and leave the flipper with nothing, especially if one considers the trader pulling the trigger on several of these kinds of trades with realized losses, trade after trade; the losing streaks can add up pretty quick. The individuals (or groups) pushing this kind of strategy are the same folks who will tell you that 99.99% of all pink sheets stocks are scams and that "...you gotta play the pumps and dumps...", which suggests that all the while knowing or thinking they know the stock is a scam, they suggest to nevertheless get in and play it for a flip trade. They are reckless!!! One must consider why such individuals push this kind of agenda all the while bashing PK stocks each and every day of their lives. IMO most are short selling MMs who get on the boards to try to sway sentiment of the retail sheep so they can flip daily and continue to fleece those who actually listen to their mindless incoherent garbage.

Mr Allinder, where is the 10K????

$RFMK

Rapid Fire Marketing, Inc. (RFMK) Stock Research Links

RFMK Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

NAMSA, AMS Partner to Fast-Track Tissue-Healing Tech

Updated Category News Views 97

Streamlining the Path to Market I tell you, the medical device sector is no walk in the park these days. Between the regulators breathing down your neck and the endless red tape, getting a new product from the lab to the hospital floor can feel like running a marathon in quicksand. That's why this deal between NAMSA and Advanced Medical Solutions (AMS) has me taking a...

Continue Reading
VILVA's Global Reach: Power Testing's Next Phase

Updated Category News Views 23

A Power Play on Global Markets Taking a page from its relentless pursuit of quality and innovation, VILVA Electronics is bolstering its foothold on the international stage. Based in Shenzhen, this savvy player is reaching out for strategic partners like fishing for that perfect bite, hoping to reel in catches that understand the nitty-gritty of the local ponds—their...

Continue Reading
AI Faces Accountability Trials in Business 2027

Updated Category News Views 105

Charting the AI Accountability Course In 2027, the corporate AI landscape won't be the Wild West anymore; it's morphing into a structured battlefield where the winners will be those who successfully enforce accountability. The hands-off, carte blanche days of AI are fading fast, and businesses are starting to scrutinize the AI tools they've been throwing money at. "The...

Continue Reading
Global Vineyards List: New Entrants & Rankings Unveiled

Updated Category News Views 212

Vineyards' Global Ranking Unveiled Wine enthusiasts and globetrotters have something to toast about this November. The 50 Best Vineyards just expanded its ranking to reveal the vineyards sitting in spots 51 through 100 for 2026. This list, spotlighting some of the globe's finest wine destinations, precedes the main awards ceremony set for November 18 in Santiago, Chile....

Continue Reading
Net at Work Enhances Offering with K&R Acquisition

Updated Category News Views 24

Net at Work Makes a Strategic Move Out of the blue, Net at Work, a prominent figure in the North American tech scene, zeroes in on boosting their expertise with the acquisition of K&R Consulting Group. It's all about expanding their horizons, and snagging K&R doesn't just double down on their ERP game, it broadens their client base in manufacturing, distribution, and...

Continue Reading
Goodyear's Strategic Shift: New Leadership, New Path

Updated Category News Views 100

Big Shoes, Bigger Expectations Who's steering the Goodyear ship now that Mark Stewart's out the door? Roger Wood's the name, interim CEO is the game. Don't fret too much—the board's hustling to nail down a permanent top dog. But this isn't a musical chairs game; it's a full-on strategic shift. Goodyear's forming committees, juggling ideas, and ripping through their...

Continue Reading
Zions Bank Spurs Idaho's Small Biz Boom in 2026

Updated Category News Views 85

Riding the Small Business Tsunami in Idaho You don't hear it every day, but Idaho's small business scene is hotter than a frypan—a nod to the entrepreneurial fire blazing in the state, and Zions Bank is holding the torch. In 2026, despite dealing with the uphill battles of inflation, tariffs, and labor scarcity, those entrepreneurs still managed to carve out a spot at...

Continue Reading
California Credit Union's Toy Drive Brings Holiday Cheer

Updated Category News Views 44

California Credit Union Joins Forces for Holiday Toy Drive Alright, folks, here’s a story with a feel-good spin straight out of Glendale. California Credit Union is at it again, teaming up with the Los Angeles Boys & Girls Club to sprinkle some holiday magic on local kiddos and their families. Now, it’s the sixth year straight they’ve pulled off this toy drive...

Continue Reading
Veterinary Stories Transform Pet Care in New Docuseries

Updated Category News Views 191

Peeling Back the Scrubs: Hidden Heroes in Vet Medicine Everyone's all-hands-on-deck when it's your furball on the line, but how much do you really know about what happens in those vet offices? Finally, National Veterinary Associates (NVA) is unzipping that mystery with a no-bones-about-it docuseries, Advancing Veterinary Medicine: Our Stories, right out of Austin, Texas....

Continue Reading
Inside Kristallnacht: An XR Journey for a New World

Updated Category News Views 135

Bridging the Past with Powerful Tech: A Journey to Kristallnacht Let's cut to the chase: if there's a time in history that we all need to sear into our collective consciousness, it's Kristallnacht. Forget the mere notion of reading it from a textbook; now you can dive headfirst into the harrowing events of November 9, 1938, thanks to the cutting-edge initiative inside...

Continue Reading

Top 5 Most Recently Viewed Articles

Getinge's Early 2025 Financial Results: Insights and Strategies

Updated Category News Views 521

Sales Growth and Performance Overview Getinge has reported a strong performance for the first quarter of 2025, characterized by an organic sales growth of 6.2%. Despite facing currency headwinds, the medical technology company's positive trajectory continues to impress. The rise in order intake, marked at 2.9%, further cements Getinge's position as a key player in the...

Continue Reading
UnitedHealth's 2025 Outlook: Insights Amid Industry Challenges

Updated Category News Views 1417

UnitedHealth's Anticipated 2025 Outlook Investors eagerly await significant insights into UnitedHealth Group's (NYSE: UNH) projections for 2025 as the company prepares to release its quarterly results. This anticipation follows the recent tragic event involving executive Brian Thompson, whose murder led to the cancellation of crucial investor day presentations. With the...

Continue Reading
Industrial Nitrogen Market Poised for Significant Growth Ahead

Updated Category News Views 126

The Promising Future of the Industrial Nitrogen Market Recent analyses indicate a bright future for the global industrial nitrogen market, which is anticipated to reach a value of USD 38.29 billion in the next few years. This projection reflects a strong compound annual growth rate (CAGR) of 6.1% based on recent evaluations. The growth trend is largely driven by...

Continue Reading
Akeso Showcases Groundbreaking IL-1RAP Antibody Research

Updated Category News Views 206

Akeso Showcases Groundbreaking IL-1RAP Antibody Research Akeso, Inc. (HKEX: 9926.HK) has unveiled promising data from preclinical studies of a new monoclonal antibody known as AK135. This innovative treatment specifically targets the IL-1 receptor accessory protein (IL-1RAP) and effectively blocks multiple pro-inflammatory pathways. The recent findings were presented at a...

Continue Reading
Vor Bio's Pioneering Research in IgA Nephropathy Presentation

Updated Category News Views 164

Vor Bio Unveils Groundbreaking IgA Nephropathy Study at ASN 2025 CAMBRIDGE, Mass. -- Vor Bio, a leader in clinical-stage biotechnology focused on autoimmune diseases, is set to make a significant impact at the upcoming American Society of Nephrology’s Kidney Week 2025. They will present clinical data from a Phase 3 study conducted in collaboration with RemeGen Co., Ltd,...

Continue Reading